Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mercia M. Pacheco is active.

Publication


Featured researches published by Mercia M. Pacheco.


Clinical & Experimental Metastasis | 1998

Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations.

Mercia M. Pacheco; Mário Mourão; Edson B. Mantovani; Inês Nobuko Nishimoto; M. Mitzi Brentani

The purpose of this study was to investigate the association among matrix metalloproteinases (gelatinases A and B, stromelysin-3 (ST3) and matrilysin) mRNAs expressed in primary breast carcinomas and stan-dard prognostic parameters and clinical outcome. mRNA levels were determined by Northern analysis in samples of 81 breast cancer patients (median follow-up, 40 months) and 27 samples of uninvolved adjacent breast tissue. Proteases were expressed by the majority of the tumors and normal breast tissues examined. ST3, gelatinase A and matrilysin mRNAs were more often expressed at high levels in carcinomatous than in normal breast tissues. Differences in the distribution of gelatinase B mRNA were not found. However, paired normal tissues generally produced weaker signals when compared to matched tumor samples. Univariate analysis showed no significant association of gelatinase A and matrilysin mRNAs with the classical prognostic markers (age, menopausal status, stage, size, nodal status, vascular infiltrate, necrosis, steroid receptors, metastasis and survival). Overexpression of ST3 was more frequently found in tumors of post-menopausal women (P < 0.022). Elevated expression of gel B mRNA was associated with the presence of vascular infiltrate (P < 0.026), necrosis (P < 0.039), PR negative tumors (P < 0.014) and inversely corre-lated to the number of survivors (P < 0.021). Multivariate analysis including 68 patients for whom all information was available indicated that neither stromelysin correlated significantly with pathological, clin-ical or biochemical features. High levels of gelatinase A and B mRNAs were inversely associated with the number of survivors. Our findings suggest that measurements of gelatinase A and B mRNAs expression in breast carcinoma may help to identify patients with an agressive form of the disease. ©Lippincott Williams & Wilkins


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2002

Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: Associations with uPA, gelatinase B, and matrilysin mRNAs

Mercia M. Pacheco; L.P. Kowalski; Inês Nobuko Nishimoto; Maria Mitzi Brentani

Head and neck squamous cell carcinomas (HNSCC) are known for their invasive behavior. The invasiveness of these tumors requires proteases, some of which as urokinase‐type plasminogen activator (uPA), gelatinase B and matrilysin are regulated through AP‐1 dependent transcriptional mechanisms. AP‐1 consists of several proteins, including those encoded by the proto‐oncogenes c‐jun and c‐fos. The aim of this study was to: first, evaluate the expression levels of matrix metalloproteases (matrilysin and gelatinase B) and uPA mRNAs; second, examine whether these genes might be associated with c‐jun and c‐fos expression; third, examine the relationship between the expression of these genes and HNSCC clinico‐pathological features.


Chest | 1984

Steroid Receptors in Pulmonary Lymphangiomyomatosis

M. Mitzi Brentani; Carlos Roberto Ribeiro de Carvalho; Paulo Hilário Nascimento Saldiva; Mercia M. Pacheco; C.T.F. Oshima


Genes, Chromosomes and Cancer | 1994

Detailed deletion mapping of chromosome segment 17q12‐21 in sporadic breast tumours

Maria A. Nagai; Lidia Yamamoto; Sibeli Salaorni; Mercia M. Pacheco; M. Mitzi Brentani; Edson Mantovani Barbosa; Ricardo R. Brentani; Sylvie Mazoyer; Simon A. Smith; Bruce A.J. Ponder; Lois M. Mulligan


Clinical Cancer Research | 2000

Expression of a Novel Factor, com1, in Early Tumor Progression of Breast Cancer

Anne Hansen Ree; Mercia M. Pacheco; Marianne Tvermyr; Øystein Fodstad; M. Mitzi Brentani


International Journal of Cancer | 1986

Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: A multivariate analysis approach

Maria Mitzi Brentani; Eduardo L. Franco; Celina Tizuko F. Oshima; Mercia M. Pacheco


Anticancer Research | 1986

Steroid hormone receptors in male breast diseases.

Mercia M. Pacheco; Celina Tizuko F. Oshima; M. P. Lopes; A. Widman; Eduardo L. Franco; M. Mitzi Brentani


British Journal of Cancer | 1994

Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients

M. A. Nagai; Mercia M. Pacheco; M. M. Brentani; Lourdes A. Marques; R. R. Brentani; B A J Ponder; Lois M. Mulligan


International Journal of Cancer | 1988

Plasminogen activator expression and steroid hormone receptors in female breast cancer: a multifactorial study.

Mercia M. Pacheco; M. Mitzi Brentani; Eduardo L. Franco; Jose A. Fontelles; Dalton de Alencar Fischer Chamone; Lourdes A. Marques


Chest | 1985

Changes in the pulmonary glucocorticoid receptor content in the course of interstitial disease

Paulo Hïlário Nascimento Saidiva; Maria Mitzi Brentani; Carlos Roberto Ribeiro de Carvalho; José Otávio; Costa Auler; Débora Fernandes Calheiros; Mercia M. Pacheco

Collaboration


Dive into the Mercia M. Pacheco's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. A. Nagai

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C.T.F. Oshima

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lourdes A. Marques

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge